SHORVIA
Live / Applied — Second extension granted (statement of use) (as of 24 Nov 2025)
What this means for you
Not registered yet, but its 08 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98440668
- Mark type
- Stylized text
- Filed
- 08 Mar 2024
- Published for opposition
- 05 Nov 2024
- Attorney of record
- Hara K. Jacobs
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of central nervous system diseases and disorders
Owner
- Cerevance, Inc., Boston, MA, US
- Cerevance, Inc., Boston, MA, US
Prosecution history
- 25 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2025 — SOU EXTENSION 2 GRANTED
- 24 Nov 2025 — SOU EXTENSION 2 FILED
- 24 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 1 GRANTED
- 16 Jun 2025 — SOU EXTENSION 1 FILED
- 16 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Sept 2024 — ASSIGNED TO EXAMINER
- 08 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED